The In Vitro Diagnostics Market was valued at USD 108.30 billion in 2024, and is projected to reach USD 150.13 billion by 2030, rising at a CAGR of 5.62%. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users. ![In Vitro Diagnostics Market]( "In Vitro Diagnostics Market")
These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.
This product will be delivered within 2 business days.
These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.
In Vitro Diagnostics Market Report Highlights
- The IVD market demonstrates a high degree of innovation, driven by advancements in molecular diagnostics, next-generation sequencing (NGS), and point-of-care testing.
- The distribution channels for in vitro diagnostics (IVD) market play a critical role in how products reach healthcare facilities, laboratories, and End Users, impacting market reach and operational efficiency
- The pricing of In vitro diagnostics (IVD) products varies significantly based on product type, complexity, and application.
- Reagents held the largest share of 65.54% of the in vitro diagnostics market in 2024, driven by significant R&D efforts from leading market players aiming to develop innovative biomarker kits
- North America dominated the in vitro diagnostics industry and accounted for a 47.43% share in 2024
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Introduction of Technologically Advanced Products
3.2.1.2. Increasing Demand for PoC Testing
3.2.1.3. Growing Prevalence of Target Diseases
3.2.1.4. Increasing External Funding for R&D
3.2.2. Market Restraints Analysis
3.2.2.1. Presence of Ambiguous Regulatory Framework
3.2.2.2. High Capital Investment
3.2.2.3. High Prices of Molecular Diagnostic Tests
3.2.3. Market Opportunity Analysis
3.2.4. Supply Chain Analysis
3.2.5. Distribution Channel
3.2.5.1. Direct Sales
3.2.5.2. Distributors Network
3.2.5.3. E-commerce and Online Platforms
3.2.5.4. Major Distributors
3.3. In Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Reimbursement Overview of IVDs and LDTs
3.5. Pricing Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Introduction of Technologically Advanced Products
3.2.1.2. Increasing Demand for PoC Testing
3.2.1.3. Growing Prevalence of Target Diseases
3.2.1.4. Increasing External Funding for R&D
3.2.2. Market Restraints Analysis
3.2.2.1. Presence of Ambiguous Regulatory Framework
3.2.2.2. High Capital Investment
3.2.2.3. High Prices of Molecular Diagnostic Tests
3.2.3. Market Opportunity Analysis
3.2.4. Supply Chain Analysis
3.2.5. Distribution Channel
3.2.5.1. Direct Sales
3.2.5.2. Distributors Network
3.2.5.3. E-commerce and Online Platforms
3.2.5.4. Major Distributors
3.3. In Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Reimbursement Overview of IVDs and LDTs
3.5. Pricing Analysis
Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
4.3. Instruments
4.4. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
4.3. Instruments
4.4. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Billion)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.3.2. Instruments
5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Units)
5.3.3. Reagents
5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.3.4. Services
5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.4. Hematology
5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.4.4. Services
5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.5. Clinical Chemistry
5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.5.4. Services
5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.6.4. Services
5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.7. Coagulation
5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.7.4. Services
5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.8. Microbiology
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.8.4. Services
5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.9.4. Services
5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Billion)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.3.2. Instruments
5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Units)
5.3.3. Reagents
5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.3.4. Services
5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.4. Hematology
5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.4.4. Services
5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.5. Clinical Chemistry
5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.5.4. Services
5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.6.4. Services
5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.7. Coagulation
5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.7.4. Services
5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.8. Microbiology
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.8.4. Services
5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.9.4. Services
5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Billion)
6.3. Infectious Disease
6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.4. Diabetes
6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.6. Cardiology
6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.7. Nephrology
6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Billion)
6.3. Infectious Disease
6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.4. Diabetes
6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.6. Cardiology
6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.7. Nephrology
6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Billion)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.4. Home-care
7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Billion)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.4. Home-care
7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Billion)
8.3. Hospitals
8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4. Laboratory
8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.5. Home Care
8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Billion)
8.3. Hospitals
8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4. Laboratory
8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.5. Home Care
8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
9.1. In Vitro Diagnostics Market Share, by Region, 2024 & 2030, USD Billion
9.2. North America
9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Regulatory Landscape/Reimbursement Scenario
9.2.4.3. Competitive Insights
9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3. Europe
9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.2. U.K.
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.7. Sweden
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4. Asia Pacific
9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
9.4.2. China
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.5. Latin America
9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.3. UAE
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.4. South Africa
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.2. North America
9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Regulatory Landscape/Reimbursement Scenario
9.2.4.3. Competitive Insights
9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3. Europe
9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.2. U.K.
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.7. Sweden
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4. Asia Pacific
9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
9.4.2. China
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.5. Latin America
9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.3. UAE
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.4. South Africa
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Global Company Market Share Analysis, 2024
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. Abbott
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. Bio-Rad Laboratories, Inc
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. Siemens Healthineers AG
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. BIOMÉRIEUX
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. BD
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. QIAGEN
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Quidel Corporation
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. F. Hoffmann-La Roche Ltd.
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Danaher
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Quest Diagnostics Incorporated
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Agilent Technologies, Inc.
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
10.2. Company Categorization
10.3. Global Company Market Share Analysis, 2024
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. Abbott
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. Bio-Rad Laboratories, Inc
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. Siemens Healthineers AG
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. BIOMÉRIEUX
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. BD
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. QIAGEN
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Quidel Corporation
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. F. Hoffmann-La Roche Ltd.
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Danaher
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Quest Diagnostics Incorporated
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Agilent Technologies, Inc.
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global In Vitro Diagnostics Market, by Region, 2018-2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 5 Global In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 6 Global In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 7 Global In Vitro Diagnostics Market, by Application, 2018-2030 USD Billion
Table 8 Global In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 9 Global In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 10 North America In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 11 North America In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 12 North America In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 13 North America In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 14 North America In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 15 North America In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 16 U.S. In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 17 U.S. In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 18 U.S. In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 19 U.S. In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 20 U.S. In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 21 Canada In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 22 Canada In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 23 Canada In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 24 Canada In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 25 Canada In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 26 Mexico In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 27 Mexico In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 28 Mexico In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 29 Mexico In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 30 Mexico In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 31 Europe In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 32 Europe In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 33 Europe In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 34 Europe In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 35 Europe In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 36 Europe In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 37 U.K. In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 38 U.K. In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 39 U.K. In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 40 U.K. In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 41 U.K. In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 42 Germany In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 43 Germany In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 44 Germany In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 45 Germany America In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 46 Germany In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 47 France In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 48 France In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 49 France In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 50 France In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 51 France In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 52 Spain In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 53 Spain In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 54 Spain In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 55 Spain In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 56 Spain In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 57 Italy In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 58 Italy In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 59 Italy In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 60 Italy In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 61 Italy In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 62 Asia Pacific In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 63 Asia Pacific In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 64 Asia Pacific In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 65 Asia Pacific In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 66 Asia-Pacific In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 67 Asia-Pacific In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 68 China In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 69 China In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 70 China In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 71 China In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 72 China In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 73 Japan In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 74 Japan In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 75 Japan In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 76 Japan In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 77 Japan In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 78 India In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 79 India In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 80 India In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 81 India In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 82 India In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 83 South Korea In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 84 South Korea In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 85 South Korea In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 86 South Korea In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 87 South Korea In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 88 Australia In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 89 Australia In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 90 Australia In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 91 Australia In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 92 Australia In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 93 Latin America In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 94 Latin America In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 95 Latin America In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 96 Latin America In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 97 Latin America In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 98 Latin America In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 99 Brazil In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 100 Brazil In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 101 Brazil In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 102 Brazil In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 103 Brazil In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 104 Argentina In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 105 Argentina In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 106 Argentina In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 107 Argentina In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 108 Argentina In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 109 MEA In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 110 MEA In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 111 MEA In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 112 MEA In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 113 MEA In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 114 MEA In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 115 South Africa In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 116 South Africa In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 117 South Africa In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 118 South Africa In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 119 UAE In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 120 UAE In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 121 UAE In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 122 UAE In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 123 UAE In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 124 UAE In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion) million
Table 125 Saudi Arabia In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 126 Saudi Arabia In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 127 Saudi Arabia In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 128 Saudi Arabia In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 129 Saudi Arabia In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global In Vitro Diagnostics Market, by Region, 2018-2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 5 Global In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 6 Global In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 7 Global In Vitro Diagnostics Market, by Application, 2018-2030 USD Billion
Table 8 Global In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 9 Global In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 10 North America In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 11 North America In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 12 North America In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 13 North America In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 14 North America In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 15 North America In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 16 U.S. In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 17 U.S. In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 18 U.S. In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 19 U.S. In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 20 U.S. In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 21 Canada In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 22 Canada In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 23 Canada In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 24 Canada In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 25 Canada In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 26 Mexico In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 27 Mexico In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 28 Mexico In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 29 Mexico In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 30 Mexico In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 31 Europe In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 32 Europe In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 33 Europe In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 34 Europe In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 35 Europe In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 36 Europe In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 37 U.K. In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 38 U.K. In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 39 U.K. In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 40 U.K. In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 41 U.K. In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 42 Germany In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 43 Germany In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 44 Germany In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 45 Germany America In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 46 Germany In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 47 France In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 48 France In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 49 France In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 50 France In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 51 France In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 52 Spain In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 53 Spain In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 54 Spain In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 55 Spain In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 56 Spain In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 57 Italy In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 58 Italy In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 59 Italy In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 60 Italy In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 61 Italy In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 62 Asia Pacific In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 63 Asia Pacific In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 64 Asia Pacific In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 65 Asia Pacific In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 66 Asia-Pacific In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 67 Asia-Pacific In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 68 China In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 69 China In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 70 China In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 71 China In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 72 China In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 73 Japan In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 74 Japan In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 75 Japan In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 76 Japan In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 77 Japan In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 78 India In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 79 India In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 80 India In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 81 India In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 82 India In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 83 South Korea In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 84 South Korea In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 85 South Korea In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 86 South Korea In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 87 South Korea In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 88 Australia In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 89 Australia In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 90 Australia In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 91 Australia In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 92 Australia In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 93 Latin America In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 94 Latin America In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 95 Latin America In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 96 Latin America In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 97 Latin America In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 98 Latin America In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 99 Brazil In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 100 Brazil In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 101 Brazil In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 102 Brazil In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 103 Brazil In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 104 Argentina In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 105 Argentina In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 106 Argentina In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 107 Argentina In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 108 Argentina In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 109 MEA In Vitro Diagnostics Market, by Country, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 110 MEA In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 111 MEA In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 112 MEA In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 113 MEA In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 114 MEA In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 115 South Africa In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 116 South Africa In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 117 South Africa In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 118 South Africa In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 119 UAE In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
Table 120 UAE In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 121 UAE In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 122 UAE In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 123 UAE In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 124 UAE In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion) million
Table 125 Saudi Arabia In Vitro Diagnostics Market, by Product, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 126 Saudi Arabia In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 127 Saudi Arabia In Vitro Diagnostics Market, by Application, 2018-2030 (USD Billion)
Table 128 Saudi Arabia In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 129 Saudi Arabia In Vitro Diagnostics Market, by Test Location, 2018-2030 (USD Billion)
List of Figures
Figure 1 In Vitro Diagnostics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 In vitro diagnostic market snapshot
Figure 10 Parent market outlook, 2024
Figure 11 In vitro diagnostic market driver impact
Figure 12 Global elderly population
Figure 13 New cancer cases by year
Figure 14 In vitro diagnostic market restraint impact
Figure 15 Market entry strategy
Figure 16 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 17 Porter’s five forces analysis
Figure 18 IVD market: Product outlook and key takeaways
Figure 19 IVD market: Products movement analysis
Figure 20 Instruments market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 21 Reagents market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 22 Services market estimates and forecast, 2018-2030 (USD Billion)
Figure 23 IVD market: Technology outlook and key takeaways
Figure 24 IVD Market: Technology movement analysis
Figure 25 Immunoassay market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 26 Instruments market for immunoassay estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 27 Reagents market for immunoassay estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 28 Services market for immunoassay estimates and forecast, 2018-2030 (USD Billion)
Figure 29 Hematology market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 30 Instruments market for hematology estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 31 Reagents market for hematology estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 32 Services market for hematology estimates and forecast, 2018-2030 (USD Billion)
Figure 33 Clinical chemistry market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 34 Instruments market for clinical chemistry estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 35 Reagents market for clinical chemistry estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 36 Services market for clinical chemistry estimates and forecast, 2018-2030 (USD Billion)
Figure 37 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 38 Instruments market for molecular diagnostics estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 39 Reagents market for molecular diagnostics estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 40 Services market for molecular diagnostics estimates and forecast, 2018-2030 (USD Billion)
Figure 41 Coagulation market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 42 Instruments market for coagulation estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 43 Reagents market for coagulation estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 44 Services market for coagulation estimates and forecast, 2018-2030 (USD Billion)
Figure 45 Microbiology market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 46 Instruments market for microbiology estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 47 Reagents market for microbiology estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 48 Services market for microbiology estimates and forecast, 2018-2030 (USD Billion)
Figure 49 Others market estimates and forecast, 2018-2030 (USD Billion)billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million
Figure 50 Instruments others market estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 51 Reagents others market estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 52 Services market for other technology estimates and forecast, 2018-2030 (USD Billion)
Figure 53 IVD market: Application outlook and key takeaways
Figure 54 IVD market: Application movement analysis
Figure 55 Infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 56 Diabetes market estimates and forecast, 2018-2030 (USD Billion)
Figure 57 Oncology market estimates and forecast, 2018-2030 (USD Billion)
Figure 58 Cardiology market estimates and forecast, 2018-2030 (USD Billion)
Figure 59 Nephrology market estimates and forecast, 2018-2030 (USD Billion)
Figure 60 Autoimmune diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 61 Drug testing market estimates and forecast, 2018-2030 (USD Billion)
Figure 62 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 63 IVD market: End Use outlook and key takeaways
Figure 64 IVD treatment market: End Use movement analysis
Figure 65 Hospitals market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 66 Laboratory market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 67 Home care market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 68 Other market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 69 IVD market: test location outlook and key takeaways
Figure 70 IVD treatment market: Test location movement analysis
Figure 71 Point-of-care market estimates and forecast, 2018-2030 (USD Billion)
Figure 72 Homecare market estimates and forecast, 2018-2030 (USD Billion)
Figure 73 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 74 IVD Market: Regional outlook and key takeaways
Figure 75 IVD market: Regional movement analysis
Figure 76 North America
Figure 77 North America. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 78 U.S. key country dynamics
Figure 79 U.S. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 80 Canada key country dynamics
Figure 81 Canada market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 82 Mexico key country dynamics
Figure 83 Mexico market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 84 Europe
Figure 85 Europe market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 86 U.K. key country dynamics
Figure 87 U.K. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 88 Germany key country dynamics
Figure 89 Germany market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 90 Spain key country dynamics
Figure 91 Spain market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 92 France key country dynamics
Figure 93 France market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 94 Italy key country dynamics
Figure 95 Italy market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 96 Denmark key country dynamics
Figure 97 Denmark market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 98 Sweden key country dynamics
Figure 99 Sweden market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 100 Norway key country dynamics
Figure 101 Norway market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 102 Asia Pacific
Figure 103 Asia Pacific market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 104 Japan key country dynamics
Figure 105 Japan market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 106 China key country dynamics
Figure 107 China. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 108 India key country dynamics
Figure 109 India. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 110 South Korea key country dynamics
Figure 111 South Korea market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 112 Thailand key country dynamics
Figure 113 Thailand market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 114 Australia key country dynamics
Figure 115 Australia market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 116 Latin America
Figure 117 Latin America market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 118 Brazil key country dynamics
Figure 119 Brazil market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 120 Argentina key country dynamics
Figure 121 Argentina market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 122 MEA
Figure 123 MEA market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 124 South Africa key country dynamics
Figure 125 South Africa market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 126 UAE key country dynamics
Figure 127 UAE market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 128 Saudi Arabia key country dynamics
Figure 129 Saudi Arabia market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 130 Ansoff matrix
Figure 131 Competition categorization
Figure 132 Company market share analysis, 2024
Figure 133 Global mass spectrometry company market share analysis, 2024
Figure 134 North America mass spectrometry company market share analysis, 2024
Figure 135 Europe mass spectrometry company market share analysis, 2024
Figure 136 Asia Pacific mass spectrometry company market share analysis, 2024
Figure 137 Global immunoassay company market share analysis, 2024
Figure 138 North America immunoassay company market share analysis, 2024
Figure 139 Europe immunoassay company market share analysis, 2024
Figure 140 Asia Pacific immunoassay company market share analysis, 2024
Figure 141 Global PCR company market share analysis, 2024
Figure 142 North America PCR company market share analysis, 2024
Figure 143 Europe PCR company market share analysis, 2024
Figure 144 Asia Pacific PCR company market share analysis, 2024
Figure 145 Company market position analysis
Figure 146 Company market position analysis
Figure 147 Company market position analysis
Figure 148 Company profiles
Figure 149 Regional network map
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 In vitro diagnostic market snapshot
Figure 10 Parent market outlook, 2024
Figure 11 In vitro diagnostic market driver impact
Figure 12 Global elderly population
Figure 13 New cancer cases by year
Figure 14 In vitro diagnostic market restraint impact
Figure 15 Market entry strategy
Figure 16 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 17 Porter’s five forces analysis
Figure 18 IVD market: Product outlook and key takeaways
Figure 19 IVD market: Products movement analysis
Figure 20 Instruments market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 21 Reagents market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 22 Services market estimates and forecast, 2018-2030 (USD Billion)
Figure 23 IVD market: Technology outlook and key takeaways
Figure 24 IVD Market: Technology movement analysis
Figure 25 Immunoassay market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 26 Instruments market for immunoassay estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 27 Reagents market for immunoassay estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 28 Services market for immunoassay estimates and forecast, 2018-2030 (USD Billion)
Figure 29 Hematology market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 30 Instruments market for hematology estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 31 Reagents market for hematology estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 32 Services market for hematology estimates and forecast, 2018-2030 (USD Billion)
Figure 33 Clinical chemistry market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 34 Instruments market for clinical chemistry estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 35 Reagents market for clinical chemistry estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 36 Services market for clinical chemistry estimates and forecast, 2018-2030 (USD Billion)
Figure 37 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 38 Instruments market for molecular diagnostics estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 39 Reagents market for molecular diagnostics estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 40 Services market for molecular diagnostics estimates and forecast, 2018-2030 (USD Billion)
Figure 41 Coagulation market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 42 Instruments market for coagulation estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 43 Reagents market for coagulation estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 44 Services market for coagulation estimates and forecast, 2018-2030 (USD Billion)
Figure 45 Microbiology market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 46 Instruments market for microbiology estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 47 Reagents market for microbiology estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 48 Services market for microbiology estimates and forecast, 2018-2030 (USD Billion)
Figure 49 Others market estimates and forecast, 2018-2030 (USD Billion)billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million
Figure 50 Instruments others market estimates and forecast, 2018-2030 (USD Billion), volume, number of instruments, in thousands
Figure 51 Reagents others market estimates and forecast, 2018-2030 (USD Billion), volume, reagents, number of tests in million
Figure 52 Services market for other technology estimates and forecast, 2018-2030 (USD Billion)
Figure 53 IVD market: Application outlook and key takeaways
Figure 54 IVD market: Application movement analysis
Figure 55 Infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 56 Diabetes market estimates and forecast, 2018-2030 (USD Billion)
Figure 57 Oncology market estimates and forecast, 2018-2030 (USD Billion)
Figure 58 Cardiology market estimates and forecast, 2018-2030 (USD Billion)
Figure 59 Nephrology market estimates and forecast, 2018-2030 (USD Billion)
Figure 60 Autoimmune diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 61 Drug testing market estimates and forecast, 2018-2030 (USD Billion)
Figure 62 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 63 IVD market: End Use outlook and key takeaways
Figure 64 IVD treatment market: End Use movement analysis
Figure 65 Hospitals market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 66 Laboratory market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 67 Home care market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 68 Other market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 69 IVD market: test location outlook and key takeaways
Figure 70 IVD treatment market: Test location movement analysis
Figure 71 Point-of-care market estimates and forecast, 2018-2030 (USD Billion)
Figure 72 Homecare market estimates and forecast, 2018-2030 (USD Billion)
Figure 73 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 74 IVD Market: Regional outlook and key takeaways
Figure 75 IVD market: Regional movement analysis
Figure 76 North America
Figure 77 North America. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 78 U.S. key country dynamics
Figure 79 U.S. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 80 Canada key country dynamics
Figure 81 Canada market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 82 Mexico key country dynamics
Figure 83 Mexico market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 84 Europe
Figure 85 Europe market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 86 U.K. key country dynamics
Figure 87 U.K. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 88 Germany key country dynamics
Figure 89 Germany market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 90 Spain key country dynamics
Figure 91 Spain market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 92 France key country dynamics
Figure 93 France market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 94 Italy key country dynamics
Figure 95 Italy market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 96 Denmark key country dynamics
Figure 97 Denmark market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 98 Sweden key country dynamics
Figure 99 Sweden market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 100 Norway key country dynamics
Figure 101 Norway market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 102 Asia Pacific
Figure 103 Asia Pacific market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 104 Japan key country dynamics
Figure 105 Japan market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 106 China key country dynamics
Figure 107 China. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 108 India key country dynamics
Figure 109 India. market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 110 South Korea key country dynamics
Figure 111 South Korea market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 112 Thailand key country dynamics
Figure 113 Thailand market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 114 Australia key country dynamics
Figure 115 Australia market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 116 Latin America
Figure 117 Latin America market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 118 Brazil key country dynamics
Figure 119 Brazil market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 120 Argentina key country dynamics
Figure 121 Argentina market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 122 MEA
Figure 123 MEA market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 124 South Africa key country dynamics
Figure 125 South Africa market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 126 UAE key country dynamics
Figure 127 UAE market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 128 Saudi Arabia key country dynamics
Figure 129 Saudi Arabia market estimates and forecast, 2018-2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
Figure 130 Ansoff matrix
Figure 131 Competition categorization
Figure 132 Company market share analysis, 2024
Figure 133 Global mass spectrometry company market share analysis, 2024
Figure 134 North America mass spectrometry company market share analysis, 2024
Figure 135 Europe mass spectrometry company market share analysis, 2024
Figure 136 Asia Pacific mass spectrometry company market share analysis, 2024
Figure 137 Global immunoassay company market share analysis, 2024
Figure 138 North America immunoassay company market share analysis, 2024
Figure 139 Europe immunoassay company market share analysis, 2024
Figure 140 Asia Pacific immunoassay company market share analysis, 2024
Figure 141 Global PCR company market share analysis, 2024
Figure 142 North America PCR company market share analysis, 2024
Figure 143 Europe PCR company market share analysis, 2024
Figure 144 Asia Pacific PCR company market share analysis, 2024
Figure 145 Company market position analysis
Figure 146 Company market position analysis
Figure 147 Company market position analysis
Figure 148 Company profiles
Figure 149 Regional network map
Companies Mentioned
The major companies profiled in this In Vitro Diagnostics market report include:- Abbott
- Bio-Rad Laboratories, Inc
- Siemens Healthineers AG
- BIOMÉRIEUX
- BD
- QIAGEN
- Quidel Corporation
- F. Hoffmann-La Roche Ltd.
- Danaher
- Quest Diagnostics Incorporated
- Agilent Technologies, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 320 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 108.3 Billion |
| Forecasted Market Value ( USD | $ 150.13 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
